Degenerative Neurological and Neuromuscular Disease

Therapeutic options in chronic neurodegeneration: from experimental research to clinical practice

Why are the causes of neurodegeneration and neuroinflammation so complex? How can the scientific and medical community proceed in treating them? From the early development phases, clinical trials, regulatory approval and real-world practice, developers have introduced therapeutic options for some neurodegenerative diseases. While chronic neurodegeneration may be heterogenous in nature, the development of treatments can provide reassurance for those affected. This Thematic Series focuses on current treatment modalities and how they are used in clinical practice and to consider emerging therapies being developed for chronic neurodegeneration, alongside further developing an understanding of how these diseases affect individual abilities and functions. Discussion of these issues can help researchers improve the lives of those enduring neurodegenerative diseases, such as Parkinson’s disease, and those that are rarer, including Creutzfeldt-Jakob disease.